Probiotics and Its Associated Factors on Aflatoxin Biomarkers
Effect of Probiotics and Its Associated Factors on Aflatoxin Biomarkers Among Healthy Subjects in Serdang and Kajang, Selangor: A Twelve-week Intervention
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Serdang, Malaysia
- Teaching Hospital Universiti Putra Malaysia
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Malaysian healthy male or female adults (BMI <30kg/m2) aged 20 to 60 years who have regular bowel movement (at least 4 times/week), AFB1 >4.71 pg/mg albumin, and AFM1 > 0.88 ng/ml
Exclusion Criteria:
- History or presence of any clinically important disease or disorder (eg. cardiovascular disease, kidney disease, diabetes mellitus, etc.) which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study
- Mental status that is incompatible with the proper conduct of the study
- Functional constipation [based on Rome III diagnostic criteria with a five-point symptoms based diagnosing tool (0=never or rarely, 1=sometimes, 2=often, 3=most of the time, 4=always)]
- Diarrhoea within 2 months prior to the study start
- Allergic reaction towards probiotic, milk and with gastric problem
- Lactose intolerance
- Use of medications or/and antibiotics
- Use of probiotic, prebiotic and fibre supplements or/and laxatives during the two weeks prior to study start.
- Drug/alcohol abuse (for alcohol 4 times/day or 20 times/week)
- Pregnant
- Reported special diets such as vegetarian, vegan, or macrobiotic
- Festive (eg. Ramadan, Chinese New Year etc) 3 months before and during the study
- Participation in another intervention study one month prior to the present study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Probiotics
Subjects in probiotic group will receive fermented milk containing live cultures Lactobacillus casei Shirota (LcS), 3 x 10^10 CFU/bottle (80 ml)
|
Participants will be requested to consume the drinks (80 ml) twice a day - after lunch and dinner for 12 weeks.
|
|
Placebo Comparator: Placebo
Subjects in placebo group will receive milk drink without LcS (80 ml).
|
Participants will be requested to consume the drinks (80 ml) twice a day - after lunch and dinner for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in serum AFB1-lysine adducts (pg/mg albumin) over 16 weeks
Time Frame: From week 0 to week 16
|
Analysis of serum AFB1-lysine adducts will be done using elisa kit through HPLC.
|
From week 0 to week 16
|
|
Changes in urinary AFM1 (ng/ml) over 16 weeks
Time Frame: From week 0 to week 16
|
Analysis of urinary AFM1 will be done using elisa kit.
|
From week 0 to week 16
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in body mass index (kg/m^2) over 16 weeks
Time Frame: From week 0 to week 16
|
Changes in weight and height will be measured using weighing scale and body meter respectively.
Weight and height will be combined to report BMI in kg/m^2
|
From week 0 to week 16
|
|
Changes in waist circumference (cm) over 16 weeks
Time Frame: From week 0 to week 16
|
The parameter will be measured using measuring tape.
|
From week 0 to week 16
|
|
Changes in physical activity level (MET-min/week) over 16 weeks
Time Frame: From week 0 to week 16
|
The parameter will be examined using questionnaire based on the Global Physical Activity Questionnaire.
|
From week 0 to week 16
|
|
Changes in dietary intake over 16 weeks
Time Frame: From week 0 to week 16
|
Dietary assessment will be recorded via food frequency questionnaire (FFQ). The conversion of food frequency to the amount of food intake is carried out using the following formula: Amount of food (g/day) = frequency of intake (conversion factor) × serving size × total of serving × weight of food in one serving (Wessex Institute of Public Health, 1995). |
From week 0 to week 16
|
|
Changes in knowledge, attitude and practice (KAP) on aflatoxin over 16 weeks
Time Frame: From week 0 to week 16
|
KAP will be examined using questionnaire in bilingual (English and Bahasa Malaysia).
Knowledge towards aflatoxin is scored into two groups: know and do not know.
Attitudes and practices are categorized using likert scale with 1=strongly disagree, 2=disagree, 3=agree and 4=strongly agree.
|
From week 0 to week 16
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Assoc Prof Dr Rosita Jamaluddin, Universiti Putra Malaysia
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- PRO001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.